Compare WABC & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WABC | MDXG |
|---|---|---|
| Founded | 1972 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | N/A | N/A |
| Metric | WABC | MDXG |
|---|---|---|
| Price | $48.97 | $7.23 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $52.00 | $12.00 |
| AVG Volume (30 Days) | 112.5K | ★ 755.0K |
| Earning Date | 01-15-2026 | 10-29-2025 |
| Dividend Yield | ★ 3.74% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.59 | 0.27 |
| Revenue | $264,660,000.00 | ★ $393,442,000.00 |
| Revenue This Year | N/A | $19.13 |
| Revenue Next Year | N/A | $2.11 |
| P/E Ratio | ★ $10.70 | $26.86 |
| Revenue Growth | N/A | ★ 14.77 |
| 52 Week Low | $42.00 | $5.79 |
| 52 Week High | $56.83 | $9.71 |
| Indicator | WABC | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 56.53 | 56.44 |
| Support Level | $46.93 | $6.62 |
| Resistance Level | $49.50 | $7.06 |
| Average True Range (ATR) | 1.19 | 0.23 |
| MACD | 0.10 | 0.05 |
| Stochastic Oscillator | 67.26 | 91.11 |
Westamerica Bancorp is based in San Rafael, California. Westamerica Bancorporation runs a regional community bank and has approximately $7.5 billion in assets. The banks' net revenue is generated by net interest income. Deposit service charges make up the noninterest income sources. The bank focuses mostly on commercial clients, such as smaller businesses. Its footprint encompasses central and northern California, extending north of San Francisco to Mendocino and Lake counties, south to Kern County in central California and all the way east to Nevada County.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.